Neurological symptoms in psoriasis patients under treatment with infliximab
10.1016/j.apjtb.2015.05.020
- Author:
Elham BEHRANGI
1
;
Zahra AZIZIAN
1
;
Amir Houshang EHSANI
2
;
Forouzandeh SADRZADEH
3
;
Gholamhossein GHAFFARPOUR
3
;
Shooka ESMAEELI
4
;
Mansour DEYLAMI
5
;
Romina ESPAHBODI
5
Author Information
1. Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences
2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences
3. Iran University of Medical Sciences
4. Students Scientific Research Center (SSRC), Tehran University of Medical Sciences (TUMS)
5. Golestan University of Medical Sciences
- Publication Type:Journal Article
- Keywords:
Drug side effects;
Infliximab;
Neurological symptoms;
Psoriasis
- From:Asian Pacific Journal of Tropical Biomedicine
2015;5(10):878-879
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the neurological symptoms of psoriasis patients who used infliximab. Methods: We studied psoriasis patients who used infliximab in two referral general hospitals in Tehran from January 2013 to January 2014. We completed neurological symptoms checklists by questioning the patients. Results: Sixty patients with psoriasis were included in this study. Among them, 3 patients had sensory symptoms as side effect and one patient showed motor symptoms as side effect. There was no statistically significant difference between age, gender, and session count with the sensory and motor side effects ( P > 0.05). Conclusions: Neurological symptoms can be detected among 6% of patients under treatment with infliximab and there is no significant association between symptoms and gender, duration of drug use as well as age.
